Related Experiment Video
Updated: Aug 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-lowering: can ezetimibe help close the treatment gap?
1Baylor College of Medicine, Houston, Texas 77030, USA. rneal@bcm.tmc.edu
Abstract:
Most patients who should be on lipid-lowering therapy are not receiving it, and most patients who are receiving it are not reaching their appropriate low-density lipoprotein (LDL) goals. This is in part because physicians and patients fear side effects of statins and other lipid-lowering agents. Ezetimibe (Zetia), a new lipid-lowering drug, may help physicians close this "treatment gap" in more patients, especially in combination with a statin.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacogenomics: Identification of New Drug Targets
Bioavailability Enhancement: Drug Permeability Enhancement
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Lipids: Dietary Sources and Requirements
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution